Durability of mitral isthmus ablation with and without ethanol infusion in the vein of Marshall
Brief title: Durability of mitral isthmus ablation
Masayuki Ishimura, MD, PhD,* Masashi Yamamoto, MD, PhD,* Toshiharu Himi, MD, PhD,* Yoshio Kobayashi, MD, PhD†
From the * Department of Cardiology, Kimitsu Central Hospital, Kisarazu, Japan, and †Department of Cardiology, Chiba University Hospital, Chiba, Japan
Funding sources: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Disclosures: Yoshio Kobayashi has received remuneration for lectures from Amgen Astellas BioPharma Co., Ltd., Bristol-Myers Squibb Co., and Boehringer Ingelheim and scholarships from Medtronic Japan Co. Ltd, Daiichi Sankyo, Inc., Abbott Vascular Japan Co., Ltd., Boston Scientific Corp., Otsuka Pharmaceutical Co., Ltd., Pfizer Inc., Astellas Pharma Inc., Takeda Pharmaceutical Co., Ltd., Japan Lifeline Co., Ltd. The rest of the authors have no conflicts of interest.
Address for correspondence: Masayuki Ishimura,Department of Cardiology, Kimitsu Central Hospital, 1010 Sakurai, Kisarazu-city, Chiba Prefecture, Japan 2920853. Phone no.: +81438-36-1071, Fax no.: +81438-36-3867, E-mail: marnet0826@me.com.
Word count: 4818words